Zhejiang Jiuzhou Pharmaceutical Co., Ltd.
Contact:MrDavidMei
Tel: 86-576-88827079
Fax:86-576-8827681 49-40-85412607
Mail: sale@zbjz.cn
Home
Product categories
Company Profile
Contacts
Home > Company Profile
Company Profile  Info marked by "" is verified
Name:Zhejiang Jiuzhou Pharmaceutical Co., Ltd.
Trade Category: Manufacturer
Registered Time:
Address:99 Waisha Road , Jiaojiang District, Taizhou City , Zhejiang Province, China
Website:http://www.jiuzhoupharma.com

Zhejiang Jiuzhou Pharmaceutical Co., Ltd. is a medium-scale private enterprise, focusing in the production of APIs. It has also cross-sector investment in logistics service and real estate business. It was originately Dongshan Chemical Factory which was founded in 1973. Under the direction of the President Mr. Hua Xuande, the staff of Jiuzhou is fully executing the enterprise spirit of “Unite, Progress, Strict and Innovative". With strict management for over 30 years, Jiuzhou has kept growing.Today , Jiuzhou Pharmaceutical has become a medium to large-scale private pharmaceutical enterprise covering an area of 200,000 sq.m., with 16 wholly-invested or controlled subsidiaries, 1400 employees, total assets of RMB 809,790,000 and annual sales revenue of RMB 800 million. Adherencing to the principle of “survive through high quality”, we have set up an efficient quality control system, and our company has passed ISO9001, ISO9002 and SFDA'S (State Food and Drug Administration) GMP Inspection. All our product refining, drying and packaging workshops are designed and constructed in accord with the requirements of Class 300,000 clean area, and many clean area workshops and warehouses conform with GMP requirements. Various kinds of management are organized and executed pursuant to GMP criterion, so as to effectively control the quality of raw materials, intermediates and finished products. Seven API products including Carbamazepine and norfloxacin have passed GMP inspection, Amprolium has passed U.S.A. FDA inspection, and other five products including Ketoprofen and albendazole have obtained COS certification. The annual output of our main product Carbamazepine APIs and its series products,the quality of which reaches the world advanced level, is as high as 1,000 tons, which cover 80% of domestic market and 40% of international market, and our annual output and sales volume of it has kept ranking the top in the world for several years.